Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > News > My Top Four Emerging Micro-Cap Biotech Stocks

November 19th, 2007

My Top Four Emerging Micro-Cap Biotech Stocks

Abstract:
BioSante Pharma (BPAX) recently began trading on the Nasdaq under a new ticker in early November and the Company has recently achieved clarity from the FDA on the clinical development requirements for its low-dose testosterone transdermal gel treatment candidate for female sexual dysfunction called LibiGel. BioSante expects to launch a Phase 3 safety trial before year-end and also plans to conduct a second Phase 3 efficacy trial in early 2008. The cardiovascular safety study will involve 2,400 to 3,100 women with one year results sufficient to support a NDA filing (with a four year follow-up also required) for LibiGel along with the two Phase 3 efficacy studies, which will be shorter in duration and involve fewer women. Other recent events include the acquisition of Bradley Pharma (BDY) by privately held Nycomed. Bradley currently markets BioSante's lowest-approved dose transdermal estradiol gel for the treatment of hot flashes and the Nycomed acquisition could boost sales of Elestrin as part of a bigger company with a larger marketing budget. Finally, BioSante anticipates a licensing deal by year-end for its CaP nanotechnology in the area of cosmetic medicine as a dermal filler for the treatment of wrinkles and other applications.

Source:
seekingalpha.com

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Investments/IPO's/Splits

Nanometrics to Participate in the 6th Annual NYC Investor Summit 2017 November 16th, 2017

180 Degree Capital Corp. Leads Investment in TheStreet, Inc.; Investment Enables Removal of Capital Structure Overhang November 14th, 2017

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) October 23rd, 2017

Arrowhead Hosts Investor & Analyst R&D Day to Introduce TRiM(TM) Platform and Lead RNAi-based Drug Candidates September 14th, 2017

Nanomedicine

Nanoparticles could allow for faster, better medicine: Exposure of nanoparticles in the body allows for more effective delivery November 20th, 2017

Nanobiotix presented new clinical and pre-clinical data confirming NBTXR3ís significant potential role in Immuno-Oncology at SITC Annual Meeting November 14th, 2017

Arrowhead to Present at 29th Annual Piper Jaffray Healthcare Conference November 14th, 2017

A new way to mix oil and water: Condensation-based method developed at MIT could create stable nanoscale emulsions November 8th, 2017

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers

Report highlights opportunities and risks associated with synthetic biology and bioengineering November 22nd, 2017

Quantum optics allows us to abandon expensive lasers in spectroscopy: Lomonosov Moscow State University scientists have invented a new method of spectroscopy November 21st, 2017

Nano-watch has steady hands November 21st, 2017

Nanoparticles could allow for faster, better medicine: Exposure of nanoparticles in the body allows for more effective delivery November 20th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project